Epidemiology and medical management of stone disease

@article{Tiselius2003EpidemiologyAM,
  title={Epidemiology and medical management of stone disease},
  author={H. Tiselius},
  journal={BJU International},
  year={2003},
  volume={91}
}
  • H. Tiselius
  • Published 2003
  • Medicine
  • BJU International
  • Recurrent stone formation in the urinary tract is a common and important problem that must be considered in daily urological practice. With a prevalence of> 10% and an expected recurrence rate of ≈ 50%, stone disease has an important effect on the healthcare system. It is generally agreed that patients with uric acid/urate, cystine or infection stones always should be treated pharmacologically. For calcium stone formers the treatment should be chosen according to the severity of the disease… CONTINUE READING
    232 Citations

    Topics from this paper

    Paper Mentions

    Interventional Clinical Trial
    Despite an overall reduction in the perioperative complication rate, post operative pain management after ureteroscopic removal of stones (URS) remains a major factor delaying… Expand
    ConditionsPostoperative Pain Management, Urolithiasis
    InterventionDrug
    Recurrence Prevention in Patients with Urinary Tract Stone Disease
    • 14
    • PDF
    Who Forms Stones and Why
    • 20
    Prevention of Stone Disease
    • 26
    Therapy of nephrolithiasis: where is the evidence from clinical trials?
    • 3
    • PDF
    Alpha-blockers as medical expulsive therapy for ureteral stones.
    • 54
    • Highly Influenced
    Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense?
    • 10
    • PDF
    Kidney stone disease
    • 153

    References

    SHOWING 1-10 OF 93 REFERENCES
    Medical Prevention of Renal Stone Disease
    • 36
    STONE INCIDENCE AND PREVENTION
    • 32
    • PDF
    Factors Influencing the Course of Calcium Oxalate Stone Disease
    • 31